Enavate Sciences GP, LLC — 13F Holdings

2026 Q3  ·  8 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Enavate Sciences GP, LLC maintained a portfolio of 8 distinct positions. The most significant new addition was BRAVEHEART BIO INC, now representing 26.53% of the total fund value. The fund also reduced its exposure to ZENAS BIOPHARMA INC by 25.5%.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
8
Quarter
2026 Q3
Top Holding
ZBIO (28.1%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-8 of 8

Enavate Sciences GP, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
ZBIO
ZENAS BIOPHARMA...
Healthcare 28.14% 28.80% #1 1
Prev: #2
6.0
—
-1,000,000 -25.5%
P
S
2,919,159 $78,729,718
$9.32 +168.6%
$26.97 -7.2%
2024 Q4 13F Filing 2026-09-30 2026-11-16
IMNM
IMMUNOME INC
Healthcare 27.79% 22.17% #2 1
Prev: #3
6.5
—
no change no change
P
S
3,613,799 $77,732,816 2024 Q4 13F Filing 2026-09-30 2026-11-16
BRVE
BRAVEHEART BIO ...
Healthcare 26.53% — #3
Prev: #—
8.5
—
3,674,656 —
NEW
3,674,656 $74,228,051 2026 Q3 13F Filing 2026-09-30 2026-11-16
SION
SIONNA THERAPEU...
Healthcare 4.66% 31.56% #4 3
Prev: #1
3.4
—
no change no change
P
S
2,478,030 $13,034,438 2025 Q1 13F Filing 2026-09-30 2026-11-16
UPB
UPSTREAM BIO IN...
Healthcare 4.63% 4.93% #5 1
Prev: #6
3.4
—
no change no change
P
S
2,459,703 $12,962,635 2024 Q4 13F Filing 2026-09-30 2026-11-16
BBOT
BRIDGEBIO ONCOL...
Healthcare 3.85% 5.80% #6 2
Prev: #4
2.5
—
no change no change
P
S
2,626,946 $10,770,479 2025 Q3 13F Filing 2026-09-30 2026-11-16
CMPX
COMPASS THERAPE...
Healthcare 2.90% 4.94% #7 2
Prev: #5
2.2
—
no change no change
P
S
7,788,150 $8,099,676 2024 Q4 13F Filing 2026-09-30 2026-11-16
CAMP
CAMP4 THERAPEUT...
Healthcare 1.50% 1.80% #8 1
Prev: #7
0.6
—
-384,414 -27.0%
P
S
1,041,127 $4,206,153 2024 Q4 13F Filing 2026-09-30 2026-11-16
Showing 1-8 of 8 holdings

Unlock Full Enavate Sciences GP, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →